Medicalisation of race

Lancet. 2007 Feb 24;369(9562):702-4. doi: 10.1016/S0140-6736(07)60320-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Distribution
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Black or African American / genetics*
  • Clinical Trials as Topic
  • Drug Approval*
  • Drug Combinations
  • Gefitinib
  • Heart Failure / drug therapy*
  • Heart Failure / genetics*
  • Heart Failure / mortality
  • Humans
  • Hydralazine / therapeutic use*
  • Isosorbide Dinitrate / therapeutic use*
  • Lung Neoplasms / drug therapy
  • Middle Aged
  • Patents as Topic / legislation & jurisprudence
  • Quinazolines / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Quinazolines
  • isosorbide-hydralazine combination
  • Hydralazine
  • Isosorbide Dinitrate
  • Gefitinib